RE: https://www.dailymail.co.uk/news/article-9984055/Holy-grail-blood-test-diagnose-50-types-cancer-symp13 Sep 2021 13:25
It isn’t that people are right or wrong!
It is more the case that Parsortix is in the main unproven versus its potential. Or more specifically, science is presently discovering how technology like this can be used. So I would say the potential is very broad. Yes researchers and scientists have scratched the surface but we investors must be patient.
Let’s try and keep in the moment... What are Angle trying to achieve? Answer: to get FDA and commercial approval for Parsortix. Having previously tried to achieve this over a broad range of cancers and failed, the company are now focusing on a few cancer types to achieve these goals.
It is all about timing…